RFS
Rockefeller Financial Services Portfolio holdings
AUM
$6.34B
This Quarter Return
+7.76%
1 Year Return
+27.35%
3 Year Return
+50.55%
5 Year Return
–
10 Year Return
–
AUM
$5.01B
AUM Growth
+$5.01B
(+1.7%)
Cap. Flow
-$226M
Cap. Flow
% of AUM
-4.51%
Top 10 Holdings %
Top 10 Hldgs %
28.87%
Holding
530
New
16
Increased
84
Reduced
143
Closed
57
Top Buys
| 1 |
Abbott
ABT
|
$27.5M |
| 2 |
NFX
Newfield Exploration
NFX
|
$27.3M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$25.4M |
| 4 |
CERN
Cerner Corp
CERN
|
$18.4M |
| 5 |
Nike
NKE
|
$13.8M |
Top Sells
| 1 |
STJ
St Jude Medical
STJ
|
$59.5M |
| 2 |
Reinsurance Group of America
RGA
|
$34.5M |
| 3 |
JPMorgan Chase
JPM
|
$32.8M |
| 4 |
Capital One
COF
|
$28M |
| 5 |
MENT
Mentor Graphics Corp
MENT
|
$25.1M |
Sector Composition
| 1 | Healthcare | 21.97% |
| 2 | Financials | 15.07% |
| 3 | Industrials | 10.85% |
| 4 | Technology | 10.69% |
| 5 | Consumer Discretionary | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Exxon Mobil
XOM
$477B
| $75.1M | 1.5% |
915,550
-80,935
| -8% | -$6.64M |
|
27
United Airlines
UAL
$34.4B
| $68.5M | 1.37% |
969,769
-27,204
| -3% | -$1.92M |
|
28
Regeneron Pharmaceuticals
REGN
$59.8B
| $65M | 1.3% |
167,620
+19,275
| +13% | +$7.47M |
|
29
Illumina
ILMN
$15.2B
| $61.9M | 1.24% |
362,993
-5,172
| -1% | -$883K |
|
30
Biogen
BIIB
$20.8B
| $61.6M | 1.23% |
225,192
-4,243
| -2% | -$1.16M |
|
31
Synchrony
SYF
$28.1B
| $59M | 1.18% |
1,718,853
-22,288
| -1% | -$764K |
|
|
32
Capital One
COF
$142B
| $58.9M | 1.18% |
679,168
-322,652
| -32% | -$28M |
|
33
Baidu
BIDU
$33.1B
| $55.1M | 1.1% |
319,631
+1,318
| +0.4% | +$227K |
|
34
Cemex
CX
$13.3B
| $53.7M | 1.07% |
5,916,732
+15,000
| +0.3% | +$136K |
|
35
Vanguard Mortgage-Backed Securities ETF
VMBS
$14.6B
| $52.4M | 1.05% |
997,008
+23,116
| +2% | +$1.21M |
|
36
American Water Works
AWK
$27.5B
| $49.9M | 1% |
641,246
+7,935
| +1% | +$617K |
|
37
WEC Energy
WEC
$34.4B
| $48.4M | 0.97% |
797,526
-14,255
| -2% | -$864K |
|
38
Alphabet (Google) Class A
GOOGL
$2.79T
| $42.7M | 0.85% |
50,330
-1,730
| -3% | -$1.47M |
|
39
iShares MSCI EAFE ETF
EFA
$65.4B
| $41.6M | 0.83% |
667,508
-12,918
| -2% | -$805K |
|
40
Chevron
CVX
$318B
| $39.5M | 0.79% |
368,151
-26,327
| -7% | -$2.83M |
|
41
Merck
MRK
$210B
| $32.1M | 0.64% |
504,510
+1,429
| +0.3% | +$90.8K |
|
42
Masimo
MASI
$7.43B
| $31.5M | 0.63% |
337,881
| – | – |
|
43
Coterra Energy
CTRA
$18.4B
| $31M | 0.62% |
1,294,876
-361,894
| -22% | -$8.65M |
|
44
Healthcare Services Group
HCSG
$1.14B
| $30.9M | 0.62% |
717,940
-3,165
| -0.4% | -$136K |
|
|
ABMD
45
DELISTED
Abiomed Inc
ABMD
| $28.7M | 0.57% |
229,042
-2,580
| -1% | -$323K |
|
|
MSCC
46
DELISTED
Microsemi Corp
MSCC
| $27.5M | 0.55% |
533,156
-4,011
| -0.7% | -$207K |
|
|
NFX
47
DELISTED
Newfield Exploration
NFX
| $27.3M | 0.54% |
+738,424
| New | +$27.3M |
|
48
Colgate-Palmolive
CL
$67.7B
| $26.1M | 0.52% |
356,045
-130
| -0% | -$9.52K |
|
|
49
Alnylam Pharmaceuticals
ALNY
$58.6B
| $25.9M | 0.52% |
506,223
+495,730
| +4,724% | +$25.4M |
|
50
Ultragenyx Pharmaceutical
RARE
$3.04B
| $25.4M | 0.51% |
374,663
-5,098
| -1% | -$346K |
|